ReadYourDNA

Sulfamethoxazole

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Sulfamethoxazole

What it is

Sulfamethoxazole is a sulfonamide antibiotic: it blocks bacteria from making folate, which they need to grow. It is almost always given together with trimethoprim (co-trimoxazole, Bactrim, Septra), which blocks the next step of the same pathway, for urinary, chest and skin infections and to treat and prevent Pneumocystis pneumonia.

How genes come into it

Sulfamethoxazole is inactivated partly by NAT2 and turned by CYP2C9 into a reactive product thought to drive its hypersensitivity reactions; slow NAT2 acetylators were linked in older studies to more such reactions. In people with G6PD deficiency, sulfonamides can cause haemolysis. Studies have also looked at GCLC, which helps make glutathione. The findings come from a few studies, and there is no CPIC or DPWG guideline.

What research found

Every published finding on gene variants and Sulfamethoxazole. Upload your DNA file to see which of these rows apply to you.

Rated evidence (2 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

G6PD G6PD B (reference), G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like: Level 3. Toxicity: Hemolysis. 3.

GCLC rs761142: Level 3. Toxicity: HIV infectious disease. 1.

Metabolism (2 findings)

Studies of how quickly the body processes this medication.

NAT2 NAT2*4, NAT2*6, NAT2*7, NAT2*16: NAT2 *4/*4 (assigned as rapid acetylator phenotype) is associated with increased metabolism of sulfamethoxazole in people with Kidney Transplantation as compared to NAT2 *16/*6 + *6/*6 + *6/*7 + *7/*7 (assigned as slow acetylator phenotype) .

CYP2C9 rs1057910: Genotype AC is not associated with metabolism of sulfamethoxazole in people with Kidney Transplantation as compared to genotype AA.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Bactrim (Sulfonamides)

Dapsone (Sulfonamides)

Actemra (IL-6 Inhibitors)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com